Researchers at Citrini Research, an independent financial analysis firm founded by James Van Geelen, collaborated with Anthropic to test whether individuals without laboratory experience could use artificial intelligence to design a working drug. Using Claude’s frontier AI models, the team successfully designed novel drugs that worked when tested. This experiment has spawned a new investment thesis in the AI-assisted biotechnology sector.
Source: Read the original article
Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
